Cromolyn clinical trials
Also written Sodium Cromoglycate, Gastrocrom and NasalCrom.
Its developmentBy 4 companies, company by company8 company-led studies, furthest phase 3: when each phase was reached, its deals, target and what is ahead.How each study uses cromolyn is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the cromolyn studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 28 May 1982 · INTAL · NDA 018596 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2012 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 14
AZTherapies, Inc. (4) · LEO Pharma (2) · Universitaire Ziekenhuizen KU Leuven (2) · Northwestern University (1) · University of Tennessee (1) · University of California, San Diego (1) · Shiraz University of Medical Sciences (1) · Johns Hopkins University (1)
Often tested with
Tested in the same studies.
Cetirizine (1) · Ibuprofen (1) · Guanfacine (1) · Ketotifen (1) · Choline (1) · Efavirenz (1) · Adebrelimab (1) · Pegylated granulocyte colony-stimulating factor (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test cromolyn.
- Dec 2026Reverse Triple Negative Immune Resistant Breast CancerPhase 2 · Fudan University
- Mar 2027PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSPhase 2 · PhenoNet, Inc.
- Jun 2027Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung CancerPhase 1 · Carcinex Inc
Studies
Open first, then newest update. How each study uses cromolyn is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 22
- Guanfacine and Cromolyn Sodium for POTS: The DBPOTS TrialNot yet recruitingEarly Phase 1Johns Hopkins UniversityNCT07757555Written as Cromolyn SodiumHow we know
- Mast Cell Treatment in Post-tick Bite Illness (PTBI)Not yet recruitingPhase 2University of North Carolina, Chapel HillNCT07526558Written as Cromolyn SodiumHow we know
- Reverse Triple Negative Immune Resistant Breast CancerRecruitingPhase 2Fudan UniversityNCT05076682Written as Sodium CromoglicateHow we know
- Novel Strategies for Reducing Burn Scar ItchRecruitingPhase 3The University of Texas Medical Branch, GalvestonNCT06801626Written as Famotidine and 4% topical cromolyn sodiumHow we know
- PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSRecruitingPhase 2PhenoNet, Inc.NCT07142291Written as Cromolyn Sodium (34.2 mg BID)How we know
- Inhaled Cromolyn Sodium in Patients With Locally Advanced Lung CancerNot yet recruitingPhase 1Carcinex IncNCT07675876Written as Cromolyn SodiumHow we know
- Cromoglicate Adjunctive Therapy for Outpatients With SchizophreniaRecruitingPhase 1/2Vishwajit Nimgaonkar, MD PhDNCT03794076Written as CromoglycateHow we know
- Cromoglicate in PsoriasisCompletedPhase 2LEO PharmaNCT01722812Written as CromoglicateHow we know
- Cromoglicate in MastocytosisTerminatedPhase 2LEO PharmaNCT01701843Written as CromoglicateHow we know
- Mast Cells in Male Pelvic Pain and and Lower Urinary Tract DysfunctionCompletedEarly Phase 1Northwestern UniversityNCT03167216Written as Cromolyn SodiumHow we know
- Cromolyn Sodium for Treatment of COVID-19 PneumoniaTerminatedPhase 3Texas Tech University Health Sciences Center, El PasoNCT05077917Written as Cromolyn SodiumHow we know
- Mast Cells in Acid-induced Intestinal PermeabilityTerminatedPhase 4Universitaire Ziekenhuizen KU LeuvenNCT02664051Written as NalcromHow we know
- Oral Cromolyn Sodium for the Treatment of Eosinophilic EsophagitisCompletedPhase 4University of TennesseeNCT02371941Written as oral cromolyn sodiumHow we know
- Influence of Cromones on Eucapnic Hyperventilation (EVH)-Test in Young (Elite) Athletes Who Tested Positive for EIB.TerminatedPhase 3Universitaire Ziekenhuizen KU LeuvenNCT04408664Written as Sodium CromoglycateHow we know
- Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy VolunteersCompletedPhase 1AZTherapies, Inc.NCT04570644Written as ALZT-OP1 (cromolyn and ibuprofen) ALZT-OP1a (cromolyn) and ALZT-OP1b (ibuprofen)How we know
- Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)WithdrawnPhase 2AZTherapies, Inc.NCT03202147Written as CromolynHow we know
- Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's DiseaseCompletedPhase 3AZTherapies, Inc.NCT02547818Written as ALZT-OP1aHow we know
- A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS DiseaseTerminatedPhase 2AZTherapies, Inc.NCT04428775Written as ALZT-OP1a (cromolyn)How we know
- An Analysis of the Effect of Topical Cromolyn Sodium on Rosacea-associated ErythemaCompletedPhase 1/2University of California, San DiegoNCT01933464Written as Cromolyn SodiumHow we know
- Cromolyn Detection of Silent AspirationTerminatedPhase 1University of California, San FranciscoNCT01841307Written as Cromolyn SodiumHow we know
See all 22 studies that test cromolyn →
Given beside what is tested · 1 — cromolyn is usual care or a partner of the new treatment
Codes
What other systems call cromolyn · ClinicalTrials.gg INT007384
- MeSH (NLM) D004205Cromolyn SodiumConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Y0TK0FS77WCROMOLYNConfirmed FDA, NLM
- RxNorm 42612One source FDA
- NCI Thesaurus C61691CromolynOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D004205 | Cromolyn Sodium | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Y0TK0FS77W | CROMOLYN | Confirmed FDA, NLM |
| RxNorm | 42612 | — | One source FDA |
| NCI Thesaurus | C61691 | Cromolyn | One source FDA |
Also registered as cromolyn sodium (UNII Q2WXR1I0PK · RxNorm 3538).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.